NCT02079558View on ClinicalTrials.gov

Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section

PHASE2CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

Carbetocin with single 100 microg IV dosage was used in this investigation

DRUG

Oxytocin

Oxytocin with 30 international units (IU) IV infusion was used in this investigation

Trial Locations (1)

1985717443

Infertility and Reproductive Health Research Center, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT02079558 - Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section | Biotech Hunter | Biotech Hunter